Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renogen for Anemia in Incident Peritoneal Dialysis
NCT03286712Phase 4Completed
- Sponsor
- National Kidney and Transplant Institute
- Start
- Oct 2015
- Primary completion
- Mar 2017
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by National Kidney and Transplant Institute. Started Oct 2015; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03286712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03286712.